Partner Content Partner Content Prescient Announces Recent Appointments to the Senior Adviso... Prescient hires two new senior members to Advisory Team
Partner Content Partner Content Prescient hires senior members to Advisory PRESCIENT ADVISORY ANNOUNCES RECENT APPOINTMENTS
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
